FDA approves Etcamah (camizestrant) - FDA New Drug Approvals - Nundina

Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Etcamah (camizestrant)FDA approves Etcamah (camizestrant)4 September 2026The FDA approved Etcamah (camizestrant), a drug from Astrazeneca. Form: Tablet, Oral. Application NDA220359.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)